ClinVar Miner

Submissions for variant NM_001845.6(COL4A1):c.1438G>A (p.Gly480Arg)

dbSNP: rs1461754052
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center of Genomic medicine, Geneva, University Hospital of Geneva RCV000770969 SCV000897953 likely pathogenic Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome 2018-07-04 criteria provided, single submitter clinical testing
Invitae RCV001855735 SCV002252379 likely pathogenic not provided 2021-05-05 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the triple helix domain of COL4A1. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL4A1 variants affecting these glycine residues are significantly enriched in individuals with disease (PMID: 9016532, 17078022) compared to the general population (ExAC). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with COL4A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 627579). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 480 of the COL4A1 protein (p.Gly480Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.